Related Experiment Video
Updated: Sep 16, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation.
Anita Turk1, Sebastián Mondaca2,3, Bruno Nervi2,3,4
1Division of Hematology/Oncology, Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN.
Early-onset colorectal cancer (EOCRC) is a distinct disease requiring tailored precision oncology strategies. Advances in targeted therapies and neoadjuvant treatments are improving outcomes for this growing patient population.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Early-onset colorectal cancer (EOCRC) incidence is rising, posing challenges to conventional management.
- EOCRC is biologically distinct, influenced by genetic, behavioral, and environmental factors.
- Traditional screening and treatment approaches are insufficient for EOCRC.
Purpose of the Study:
- To review the molecular and clinical features differentiating EOCRC.
- To explore emerging precision oncology strategies for EOCRC.
- To identify key gaps in EOCRC care and propose a framework for optimization.
Main Methods:
- Review of molecular and clinical features of EOCRC.
- Analysis of precision oncology strategies including germline testing and genomic profiling.
- Examination of therapeutic advances in metastatic and localized EOCRC.
Main Results:
- Targeted therapies for BRAF V600E, KRAS G12C, HER2, and MSI-H/dMMR tumors are transforming treatment paradigms.
- Tumor sidedness and metastatic patterns are significant prognostic factors.
- Neoadjuvant immunotherapy and nonoperative management are emerging standards for localized EOCRC.
Conclusions:
- Precision oncology, including biomarker-directed therapies, is crucial for managing EOCRC.
- Multidisciplinary, lifecycle-based care is essential for improving outcomes and quality of life in EOCRC patients.
- Addressing care gaps, such as fertility preservation and pregnancy management, is vital.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

